$12.80
-0.40 (-3.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-16.23%
1Y
-32.63%
YTD
-32.63%
Open$13.27
Previous Close$13.20
Day High$13.48
Day Low$12.56
52W High$19.95
52W Low$8.32
Volume—
Avg Volume237.2K
Market Cap1.56B
P/E Ratio6.83
EPS$9.03
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
28.7
Oversold
Analyst Ratings
Strong Buy
12 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.88B | 1.43B | 1.25B |
| Net Income | 1.03B | 705.99M | 76.97M |
| Profit Margin | 54.8% | 52.1% | 6.2% |
| EBITDA | -2,977,988,790 | -2,157,962,891 | 127.47M |
| Free Cash Flow | — | — | 81.25M |
| Rev Growth | +31.1% | +31.1% | -0.7% |
| Debt/Equity | 7.75 | 7.75 | 0.17 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.81 | +4.46% | — | 1.75B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.20% | 75.0 | 644.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 593.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.00% | 71.9 | 596.26M |